{"id":"NCT00531479","sponsor":"Pfizer","briefTitle":"Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis","officialTitle":"A Prospective, Randomized Trial Comparing The Efficacy Of Anidulafungin And Voriconazole In Combination To That Of Voriconazole Alone When Used For Primary Therapy Of Proven Or Probable Invasive Aspergillosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07","primaryCompletion":"2011-04","completion":"2011-05","firstPosted":"2007-09-18","resultsPosted":"2012-04-30","lastUpdate":"2012-04-30"},"enrollment":459,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Aspergillosis"],"interventions":[{"type":"DRUG","name":"voriconazole","otherNames":["Vfend"]},{"type":"DRUG","name":"anidulafungin","otherNames":["Eraxis"]},{"type":"DRUG","name":"voriconazole","otherNames":["Vfend"]}],"arms":[{"label":"Voriconazole","type":"ACTIVE_COMPARATOR"},{"label":"Voriconazole and Anidulafungin","type":"EXPERIMENTAL"}],"summary":"This study compares the effectiveness and safety of the combination of anidulafungin and voriconazole compared to that of voriconazole alone (which is generally considered the standard of care) for the treatment of Invasive Aspergillosis.","primaryOutcome":{"measure":"All-cause Mortality at Week 6 in Participants With Proven or Probable Invasive Aspergillosis","timeFrame":"Day 1 to Day 42 (Week 6)","effectByArm":[{"arm":"Voriconazole/Anidulafungin","deltaMin":26,"sd":null},{"arm":"Voriconazole / Placebo","deltaMin":39,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0434"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":107,"countries":["United States","Australia","Belgium","Brazil","Canada","Czechia","France","Germany","Greece","India","Italy","Netherlands","Peru","Poland","Portugal","Russia","Singapore","South Korea","Spain","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["25599346","24914120","24913161"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A8851009&StudyName=Anidulafungin%20Plus%20Voriconazole%20versus%20Voriconazole%20For%20The%20Treatment%20Of%20Invasive%20Aspergillosis"]},"adverseEventsSummary":{"seriousAny":{"events":115,"n":228},"commonTop":["Nausea","Diarrhoea","Pyrexia","Oedema peripheral","Hypokalaemia"]}}